Integral Secures $6.9 Million Seed Round led by Haystack to Maximize Data Privacy and Quality

Vitruveo Surpasses $1 Million Milestone in NFT Sales, Strengthens Ecosystem with Successful Fundraising

New Software by Integral Enables Companies to Maximize Dataset  Customization and Privacy

The General Partnership, Virtue Ventures, Caffeinated Capital, Array Ventures, GreatPoint Ventures, LiveRamp Ventures, Venrex, and Also Capital also Invest to Support the First Privacy Preserving Data Compliance Software Built for Pharma, Life Sciences, and Healthcare Enterprises

Integral, an innovator in safeguarding privacy and maximizing data quality, today announced it raised a $6.9 million seed round to protect sensitive health data and provide automated expert certification software that enables health and life sciences companies access to compliant, rich, de-identified data in hours, rather than months. The seed round was led by Haystack, The General Partnership, and Virtue Ventures, with additional support from Also Capital, Array Ventures, Caffeinated Capital, GreatPoint Ventures, LiveRamp Ventures, and Venrex.

“We created Integral to achieve this goal, ensuring personal information is protected and people’s privacy rights are respected. By prioritizing privacy and building trust with the public, researchers can unlock more value from data, which leads to better clinical trials, medications, products, technologies, and more.”

Integral is backed by experts in healthcare and technology, including advisors to the company, Jason Brenner, Regional Vice President for Healthcare and Life Sciences at LiveRamp, and Dr. Bradley Malin, Vice Chair for Research and Professor of Biomedical Informatics at Vanderbilt University. Angel investors in the company include Andrew Arruda, co-founder and CEO at Flexpa; Abhishek Chandra, co-founder and CEO at Recora Health; Joel Jewitt, co-founder and Vice President at LiveRamp; Michel Tricot, co-founder and CEO at Airbyte; Sam Whitaker, founder and CEO at Mural Health; and others.

Founded by Shubh Sinha, CEO and John Kuhn, CTO, Integral streamlines dataset creation by automating the de-identification and compliance certification process. Personal and highly revealing healthcare data such as medical records, health histories, and genetic information, when combined with non-healthcare data such as social media activity, purchasing history, and location data, give researchers a deep, holistic understanding of a person’s health and lifestyle. While this combined data set enhances healthcare research and improves health outcomes, it can pose a significant threat to people’s privacy by potentially exposing sensitive information about individuals.

Sinha and Kuhn created Integral with a shared vision: Allow healthcare companies to work with healthcare data at unprecedented speed by de-identifying and certifying data through automation. Before Integral, companies were forced to rely on expert certifications conducted by consultants. This heavily manual, human-led process often took several months and left usable data on the table. Integral provides higher quality data and expert Certification-as-a-Service software, enabling customers to work with better data in nearly real-time.

Marketing Technology News: Sharethrough Partners With White Bullet To Drive A Safer, Cleaner, Higher-Performing Media Ecosystem

“Combining healthcare and non-healthcare data can transform healthcare research and innovation. John and I asked why healthcare companies couldn’t buy and analyze data as quickly as retailers like Target or Walmart, and we’ve made that possible with Integral. We’ve proven and will continue to prove that speed, accuracy, and privacy can be treated equally, even when working with highly regulated data,” said Sinha. “We created Integral to achieve this goal, ensuring personal information is protected and people’s privacy rights are respected. By prioritizing privacy and building trust with the public, researchers can unlock more value from data, which leads to better clinical trials, medications, products, technologies, and more.”

“Integral addresses a critical need for data privacy automation within life sciences and healthcare organizations, and we see this as a core workflow for these large customers over the coming years,” said Aashay Sanghvi, Partner, Haystack. “By streamlining privacy compliance, Integral enables companies to operate with data safely and expediently, which helps them get new treatments to market faster and serve patients better.”

The company has already brought on highly experienced healthcare expert Timothy Nobles, who brings 18+ years of experience in large-scale, privacy-preserving data solutions in Healthcare and FinTech. Timothy will bolster commercial efforts as Integral broadens and scales go-to-business capabilities in its key markets and further develops proprietary platform capabilities with this new round of funding.

According to Amruta Moktali, Chief Product Officer at Skyflow, an Integral partner, “We are seeing incredible momentum for adoption of LLM in regulated industries like healthcare. Skyflow’s data privacy vault offers a complete data privacy layer for LLMs. Our partnership with Integral allows our customers to get expert certification in days rather than weeks and months.”

September is already shaping up to be eventful for Integral, as it will soon announce the launch of its privacy analytics suite in conjunction with the team’s attendance at Pharma East 2023.

Marketing Technology News: MarTech Interview with Kala Halbert, Director of Marketing, Prophia

Picture of Business Wire

Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

You Might Also Like